-
Dalfopristin
- indication:For the treatment of bacterial infections (usually in combination with quinupristin).
- pharmacologypharmacology:
- mechanism: The site of action of dalfopristin is the bacterial ribosome. Dalfopristin has been shown to inhibit the early phase of protein synthesis.
- toxicity:
- absorprion:
- halflife: The elimination half-life is approximately 0.70 hours.
- roouteelimination:
- volumedistribution:
- clearance: